Title : Lessons from phase III clinical trials on anti-VEGF therapy for cancer.

Pub. Date : 2006 Jan

PMID : 16407877






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Furthermore, addition of vatalanib, a kinase inhibitor developed as a VEGF receptor-selective agent, to chemotherapy did not show a similar benefit in metastatic colorectal cancer patients. vatalanib vascular endothelial growth factor A Homo sapiens